{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T20:13:07Z","timestamp":1768680787585,"version":"3.49.0"},"reference-count":97,"publisher":"Informa UK Limited","issue":"1","funder":[{"name":"provided funding"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Vaccines"],"published-print":{"date-parts":[[2021,1,2]]},"DOI":"10.1080\/14760584.2021.1878030","type":"journal-article","created":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T08:20:08Z","timestamp":1610958008000},"page":"59-72","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":6,"title":["Use of Cost-Effectiveness Analyses for Decisions About Vaccination Programs for Meningococcal Disease in the United States, United Kingdom, The Netherlands, and Canada"],"prefix":"10.1080","volume":"20","author":[{"given":"Liping","family":"Huang","sequence":"first","affiliation":[{"name":"Health Economics and Outcomes Research, Collegeville, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josephine","family":"Mauskopf","sequence":"additional","affiliation":[{"name":"Health Economics Department, RTI Health Solutions, 3040 East Cornwallis Road, Research Triangle Park, North Carolina, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ray","family":"Farkouh","sequence":"additional","affiliation":[{"name":"Health Economics and Outcomes Research, Collegeville, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Masaquel","sequence":"additional","affiliation":[{"name":"Market Access and Outcomes Strategy Departments, RTI Health Solutions, 3040 East Cornwallis Road, Research Triangle Park, Research Triangle Park, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2021,2,18]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.08.008"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.04.070"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2019.103571"},{"key":"cit0004","unstructured":"Centers for Disease Control and Prevention. Meningococcal disease: surveillance; 2019 [2020 Jan 13]. Available from: https:\/\/www.cdc.gov\/meningococcal\/surveillance\/index.html"},{"key":"cit0005","unstructured":"Government of Canada. Notifiable diseases on-line Canada [cited 2020 Apr 17]. Available from: https:\/\/diseases.canada.ca\/notifiable\/\u200ccharts?c=cc#d=74&a=1&s=1&y=1991%2C2017&o=r&gb=d&ax=y&cdl=74&ct=bar; 2020"},{"key":"cit0006","unstructured":"European Centre for Disease Prevention and Control (ECDC). Invasive meningococcal disease \u2013 annual epidemiological reports for 2015 [cited 2020 May 2]. Available from: https:\/\/www.ecdc.europa.eu\/en\/publications-data\/invasive-meningococcal-disease-annual-epidemiological-report-2015"},{"key":"cit0007","unstructured":"European Centre for Disease Prevention and Control (ECDC), Invasive meningococcal disease \u2013 annual epidemiological reports for 2016 [cited 2020 May 2]. Available from: https:\/\/www.ecdc.europa.eu\/en\/publications-data\/invasive-meningococcal-disease-annual-epidemiological-report-2016"},{"key":"cit0008","unstructured":"European Centre for Disease Prevention and Control (ECDC), Invasive meningococcal disease \u2013 annual epidemiological reports for 2017 [cited 2020 May 2]. Available from: https:\/\/www.ecdc.europa.eu\/en\/publications-data\/invasive-meningococcal-disease-annual-epidemiological-report-2017"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.03.007"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadohealth.2016.04.012"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1097\/MOP.0b013e32832c9668"},{"key":"cit0012","unstructured":"World Health Organization. Weekly epidemiological record; 2011 [cited 2020 Jan 7]. Available from: https:\/\/www.who.int\/wer\/2011\/wer8647\/en\/)"},{"key":"cit0013","unstructured":"World Health Organization. Meningococcal disease; 2018 [cited 2020 Jan 7]. Available from: https:\/\/www.health.ny.gov\/\u200cpublications\/2168.pdf"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.02.034"},{"key":"cit0015","unstructured":"Borrow R Recent epidemiology of meningococcal disease and impact of immunization programmes in the UK. Public Health England; 21 June 2018 [cited 2020 May 1]. Available from: https:\/\/www.meningitis.org\/getmedia\/7a77a71e-4113-48f7-b0e6-eee01a64bfe5\/Recent-epidemiology-of-meningococcal-disease-and-impact-of-immunisation-programmes-in-the-UK-Ray-Borrow"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16725-1"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.04.067"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.324.7341.809"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X05284109"},{"key":"cit0020","unstructured":"Joint Committee on Vaccination and Immunisation (JCVI). Minutes of the meeting on 19 October 2005 and attached document on proposed changes to the routine childhood immunisation schedule; 2005 [cited 2020 Jan 7]. Available from: https:\/\/webarchive.nationalarchives.gov.uk\/\u200c20120907151250\/http:\/\/www.dh.gov.uk\/ab\/JCVI\/DH_095044"},{"key":"cit0021","unstructured":"Public Health England. Changes to the meningococcal C conjugate (MenC) vaccine schedule 2013-2015: information for healthcare professionals; July 2014 [cited 2020 Apr 17]. Available from: https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/336171\/MenC_information_for_healthcare_professionals_V7_.pdf"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(10)70251-6"},{"key":"cit0023","unstructured":"Joint Committee on Vaccination and Immunisation. JCVI position statement on use of Bexsero meningococcal B vaccine in the UK; 2014 [cited 2019 Jun 11]. Available from: https:\/\/assets.publishing.service.gov.uk\/\u200cgovernment\/uploads\/system\/uploads\/\u200cattachment_data\/file\/294245\/JCVI_Statement_on_MenB.pdf"},{"key":"cit0024","unstructured":"JCVI. Minutes of the meeting on 4 February 2015. Joint Committee on Vaccination and Immunisation; 2015 [cited 2019 Jun 24]. Available from: https:\/\/app.box.com\/s\/iddfb4ppwkmtjusir2tc\/file\/229171832189"},{"key":"cit0025","unstructured":"JCVI. Minutes of the meeting on 7 October 2015. Joint Committee on Vaccination and Immunisation; 2015 [cited 2020 Jan 7]. Available from: http:\/\/qna.files.parliament.uk\/qna-attachments\/1125504\/original\/\u200cJCVI%20Minute%202015%2010%20Attached%20to%20HL16000%20and%2015999.pdf"},{"key":"cit0026","unstructured":"JCVI. Minutes of the meeting on 1 February 2017. Joint Committee on Vaccination and Immunisation; 2017 [cited 2020 Apr 18]. Available from: http:\/\/www.nitag-resource.org\/sites\/default\/files\/\u200c3d9769b85796db91fb8ec14df1c0f790ca08fc76_1.pdf"},{"key":"cit0027","unstructured":"JCVI interim position statement on use of Bexsero meningococcal B vaccine in the UK; July 2013 [cited 2020 May 2]. Available from: https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/224896\/JCVI_interim_statement_on_meningococcal_B_vaccination_for_web.pdf"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.03.034"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2014-306030"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g6759"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.2014.878654"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.05.101"},{"key":"cit0033","unstructured":"JCVI. Minutes of the meeting on Wednesday, 2 October 2013. Joint Committee on Vaccination and Immunisation; 2013 [cited 2019 Nov 14]. Available from: https:\/\/app.box.com\/s\/iddfb4ppwkmtjusir2tc\/\u200cfile\/229171937659"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g5725"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2015-308928"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.11.076"},{"key":"cit0037","unstructured":"Joint Committee on Vaccination and Immunisation (JCVI). Minutes of the meeting on 03 October 2018; 2018 [cited 2020 Jan 8]. Available from: https:\/\/app.box.com\/s\/iddfb4ppwkmtjusir2tc\/\u200cfile\/349905639306"},{"key":"cit0038","unstructured":"Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control (CDC). ACIP: evidence to recommendations framework [last updated 7 June 2018; cited 2020 Apr 19]. Available from: https:\/\/www.cdc.gov\/\u200cvaccines\/\u200cacip\/\u200crecs\/\u200cgrade\/\u200c\u200cdownloads\/ACIP-508.pdf"},{"key":"#cr-split#-cit0039.1","unstructured":"Centers for Disease Control and Prevention. Active Bacterial Core Surveillance (ABCs) from 1993-2013 [page last reviewed 7 June 2020"},{"key":"#cr-split#-cit0039.2","unstructured":"cited 2020 May 3]. Available from: https:\/\/www.cdc.gov\/abcs\/reports-findings\/surv-reports.html"},{"key":"#cr-split#-cit0040.1","unstructured":"Centers for Disease Control and Prevention. Enhanced Surveillance reports, 2015-2017 [page last reviewed 31 May 2019"},{"key":"#cr-split#-cit0040.2","unstructured":"cited 2020 May 3]. Available from: https:\/\/www.cdc.gov\/meningococcal\/surveillance\/index.html#enhanced-reports"},{"issue":"7","key":"cit0041","first-page":"1","volume":"54","author":"Bilukha OO","year":"2005","journal-title":"MMWR Recomm Rep"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.1016\/S0749-3797(02)00462-2"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2004-2514"},{"key":"cit0044","doi-asserted-by":"publisher","DOI":"10.1086\/524041"},{"issue":"3","key":"cit0045","first-page":"72","volume":"60","author":"Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control (CDC)","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"cit0046","volume":"62","author":"Cohn AC","year":"2013","journal-title":"MMWR Recomm Rep"},{"key":"cit0047","first-page":"1265","volume":"56","author":"Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC)","year":"2007","journal-title":"MMWR"},{"issue":"17","key":"cit0048","first-page":"462","volume":"57","author":"Advisory Committee on Immunization Practices (ACIP)","year":"2008","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"cit0049","first-page":"52","volume":"62","author":"Centers for Disease Control and Prevention (CDC)","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"cit0050","doi-asserted-by":"publisher","DOI":"10.1097\/MOP.0000000000000093"},{"key":"cit0051","unstructured":"Ortega-Sanchez I. Advisory Committee on Immunization Practices. Cost effectiveness of meningococcal vaccination in infants and toddlers in the United States. Presented at Advisory Committee on Immunization Practices (ACIP); Atlanta, Georgia; October 25, 2011 [cited 2020 Jan 14]. Available from: https:\/\/www.cdc.gov\/vaccines\/acip\/\u200cmeetings\u200c\/downloads\/min-archive\/min-oct11.pdf"},{"key":"cit0052","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix993"},{"key":"cit0053","unstructured":"Centers for Disease Control and Prevention. CDC: 2015 Enhanced Meningococcal Disease Surveillance (EMDS) Report; September 2017 [cited 2020 May 2]. Available from: https:\/\/www.cdc.gov\/meningococcal\/downloads\/NCIRD-EMS-Report-2015.pdf"},{"key":"cit0054","unstructured":"Centers for Disease Control and Prevention. CDC: 2018 Enhanced Meningococcal Disease Surveillance (EMDS) Report [cited 2020 May 2]. Available from: https:\/\/www.cdc.gov\/meningococcal\/downloads\/NCIRD-EMS-Report-2018.pdf"},{"key":"cit0055","doi-asserted-by":"publisher","DOI":"10.3201\/eid2503.181574"},{"issue":"22","key":"cit0056","first-page":"608","volume":"64","author":"Folaranmi T","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"cit0057","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6441a3"},{"issue":"5","key":"cit0058","doi-asserted-by":"crossref","first-page":"e20190342","DOI":"10.1542\/peds.2019-0342","volume":"143","author":"Mbaeyi SA","year":"2019","journal-title":"Pediatrics"},{"key":"cit0059","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piz024"},{"key":"cit0060","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2018.09.020"},{"key":"cit0061","unstructured":"National Institute for Public Health and the Environment (RIVM) [cited 2020 Jul 12]. Available from: www.rivm.nl"},{"key":"cit0062","unstructured":"Knol MJ, de Melker HE, Berbers GAM, et al. Meningococcal disease in the Netherlands. RIVM report 2017-0031, Dutch National Institute for Public Health and the Environment; 2017 [cited 2019 Jun 11]. Available from: http:\/\/www.rivm.nl\/\u200cbibliotheek\/rapporten\/2017-0031.pdf"},{"key":"cit0063","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-12-35"},{"key":"cit0064","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2004.06.019"},{"key":"cit0065","doi-asserted-by":"publisher","DOI":"10.1586\/erv.09.48"},{"key":"cit0066","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0065036"},{"issue":"16","key":"cit0067","first-page":"18","volume":"23","author":"Knol Mirjam J","year":"2018","journal-title":"Euro Surveill"},{"key":"cit0068","first-page":"494492","volume-title":"In: bioRxiv","author":"van Hoek AJ","year":"2018"},{"key":"cit0069","doi-asserted-by":"publisher","DOI":"10.4161\/hv.23888"},{"key":"cit0070","unstructured":"Health Council of the Netherlands. Vaccination against meningococcal disease. Publication no. 2018\/28. The Hague: Health Council of the Netherlands 2018; 2018 [cited 2020 Jan 14]. Available from: https:\/\/www.healthcouncil.nl\/documents\/advisory-reports\/2018\/12\/19\/vaccination-against-meningococcal-disease"},{"key":"cit0071","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/431428"},{"key":"cit0072","unstructured":"An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI): Canadian immunization guide chapter on influenza and statement on seasons influenza vaccine for 2019-2020; 2019 [cited 2020 Apr 21]. Available from: https:\/\/www.hss.gov.nt.ca\/\u200cprofessionals\/sites\/professionals\/files\/resources\/canadian-immunization-guide-chapter-influenza.pdf"},{"key":"cit0073","unstructured":"Public Health Agency of Canada. An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI): Update on Quadrivalent Meningococcal Vaccines available in Canada; April 2015 [cited 2020 May 3]. Available from: https:\/\/www.canada.ca\/content\/dam\/phac-aspc\/documents\/services\/publications\/healthy-living\/update-quadrivalent-meningococcal-vaccines-available-canada-eng.pdf"},{"key":"#cr-split#-cit0074.1","unstructured":"Roy M, Saboui M, Tsang R Invasive meningococcal disease in Canada, 2012 to 2016, Canadian Immunization Conference (2018), Poster-Abstract Book, P26"},{"key":"#cr-split#-cit0074.2","unstructured":"2018 [cited 2020 May 7]. Available from: https:\/\/cic-cci.ca\/wp-content\/uploads\/2018\/11\/CIC18_Poster-Abstract-Book.pdf"},{"key":"cit0075","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/8901847"},{"issue":"2","key":"cit0076","first-page":"85","volume":"54","author":"Halperin SA","year":"2010","journal-title":"J Can Chiropr Assoc"},{"key":"cit0077","first-page":"2","volume":"27","author":"National Advisory Committee on Immunisation (NACI)","year":"2001","journal-title":"Can Commun Dis Rep"},{"key":"cit0078","first-page":"1","volume":"31","author":"National Advisory Committee on Immunisation","year":"2005","journal-title":"Can Commun Dis Rep"},{"issue":"11","key":"cit0079","first-page":"1","volume":"33","author":"National Advisory Committee on Immunization (NACI)","year":"2007","journal-title":"Can Commun Dis Rep"},{"key":"cit0080","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2003.09.022"},{"key":"cit0081","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2006.02.010"},{"key":"cit0082","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.04.071"},{"issue":"3","key":"cit0083","first-page":"1","volume":"36","author":"National Advisory Committee on Immunization (NACI)","year":"2009","journal-title":"Can Commun Dis Rep"},{"issue":"3","key":"cit0084","first-page":"1","volume":"33","author":"National Advisory Committee on Immunization (NACI)","year":"2007","journal-title":"Can Commun Dis Rep"},{"key":"cit0085","unstructured":"Government of Quebec. Quebec Immunization Program; 2020 [cited 2020 Aug 28]. Available from: https:\/\/www.quebec.ca\/en\/health\/advice-and-prevention\/vaccination\/quebec-immunisation-program\/#c25405"},{"key":"cit0086","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000001512"},{"key":"cit0087","unstructured":"National Advisory Committee on Immunization (NACI). An Advisory Committee Statement: the use of bivalent factor H binding protein meningococcal serogroup B (MenB-fHBP) vaccine for the prevention of meningococcal B disease, 2019. 2019; [cited 2020 Apr 22]. Available from: https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/vaccines-immunization\/bivalent-factor-h-binding-protein-meningococcal-serogroup-b-prevention-meningococcal-b-disease.html"},{"key":"cit0088","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.07.096"},{"key":"cit0089","doi-asserted-by":"publisher","DOI":"10.17269\/s41997-019-00275-4"},{"key":"cit0090","doi-asserted-by":"publisher","DOI":"10.1007\/s10198-019-01129-z"},{"key":"cit0091","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhealeco.2014.02.001"},{"key":"cit0092","doi-asserted-by":"publisher","DOI":"10.2307\/1061672"},{"key":"cit0093","doi-asserted-by":"publisher","DOI":"10.1023\/A:1014020027011"},{"key":"cit0094","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2020.06.018"}],"container-title":["Expert Review of Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14760584.2021.1878030","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T13:23:13Z","timestamp":1620480193000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14760584.2021.1878030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,2]]},"references-count":97,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1,2]]}},"alternative-id":["10.1080\/14760584.2021.1878030"],"URL":"https:\/\/doi.org\/10.1080\/14760584.2021.1878030","relation":{},"ISSN":["1476-0584","1744-8395"],"issn-type":[{"value":"1476-0584","type":"print"},{"value":"1744-8395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-10-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-01-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}